Deutsche Bank Initiates CONMED With Buy

Analysts at Deutsche Bank initiated coverage on

with a Buy rating. The target price for CONMED is set to $63. CONMED shares have gained 7.29 percent over the past 52 weeks, while the S&P 500 index has surged 11.87 percent in the same period. CONMED shares closed at $50.16 on Friday.